Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Data on immunization discussed by D. Holland and colleagues
September 24th, 2008
According to recent research from Auckland, New Zealand, "Enhanced influenza vaccines are needed to provide improved protection for elderly individuals. The intradermal vaccination route was hypothesized to provide immunogenicity superior to that provided by the intramuscular vaccination route." "In a multicenter, randomized study, 1107 volunteers > 60 years of age received intradermal trivalent inactivated influenza vaccine containing 15 or 21 mu g of hemagglutinin per strain or intramuscular control vaccine. Intradermal vaccines used a novel microinjection system designed to ensure easy, convenient, consistent vaccination. The primary end points of the study were...
Source: Vaccine Weekly (2008-09-24)
|
